Protagonist Therapeutics
PTGX | NASDAQ
$124.83
-$6.12 (-4.67%)
At close: Nov 16, 2026, 4:00 PM ET
$122.34
-$2.49 (-1.99%)
After-hours:
Nov 16, 2026, 7:54 PM ET
Protagonist Therapeutics Statistics
Key statistics explainedMarket Data
$8.15B
$6.82B
1.79
683.37K
71.73M
12.48%
N/A
NASDAQ
US74366E1029
Price Performance
-3.0%
-21.3%
23.9%
42.9%
47.3%
642.6%
242.8%
-3.0%
47.5%
29.0%
18.4%
Valuation
26.45
25.48
-0.01
-0.07
14.77
36.50
7.51
73.58
142.65
81.59
12.37
19.48
19.42
61.62
3.8%
1.4%
0.7%
Financial Health
$1.32B
$8.63M
$834.62M
$1.15B
19.85
19.85
0.01
0.02
0.08
12.73
0.00
85.68
5
Margins & Profitability
99.7%
58.6%
63.7%
62.0%
20.1%
10.3%
9.7%
-48.4%
Returns
29.9%
42.8%
28.9%
29.6%
29.9%
Historical Growth (CAGR)
31.5%
86.6%
37.9%
38.6%
314.4%
74.8%
-44.0%
170.6%
239.0%
Analyst Forecasts
Buy
13
4.5%
10.1%
Feb 24, 2027
-$0.15
-78.9%
$45.42M
510.7%
Fair Value Estimates
$40.07
-67.9%
$118.00
-5.5%
$173.00
38.6%
Cash Flow
$109.91M
$110.74M
$57.12M
$1.54
$1.53
19.9%
Income Statement
$551.69M
$550.18M
$323.1M
$351.43M
$342.26M
$4.72
$3.91M
$2.43M
141
Add to Watchlist
Select watchlists to add or remove PTGX